Vimarsana
Biggest News Aggregation in the World

Page 21 - Meta Analysis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Meta Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Meta Analysis Today - Breaking & Trending Today

Solid Therapeutic Hierarchy for EoE Still Unclear - Vimarsana News

Solid Therapeutic Hierarchy for EoE Still Unclear

Most available drugs for eosinophilic esophagitis (EoE) demonstrate greater efficacy than placebo, but data are too heterogenous to determine a reliable therapeutic hierarchy.

Adhering to Endocrine Therapy Is Hard. What Can Be Done? - Vimarsana News

Adhering to Endocrine Therapy Is Hard. What Can Be Done?

Poor adherence to adjuvant endocrine therapy remains an issue among patients with breast cancer. What can oncologists and patients do to improve long-term use?

Tirzepatide Tops Semaglutide for A1c Control, Weight Loss - Vimarsana News

Tirzepatide Tops Semaglutide for A1c Control, Weight Loss

A meta-analysis of studies on the two diabetes drugs shows stronger benefits with tirzepatide, with the caveat of some higher gastrointestinal effects with tirzepatide.

Does Adding Ipilimumab to Nivolumab Improve Cancer Outcomes? - Vimarsana News

Does Adding Ipilimumab to Nivolumab Improve Cancer Outcomes?

Nivolumab alone may offer equivalent clinical outcomes and lower toxicity than nivolumab plus ipilimumab in many advanced cancers other than melanoma, a new meta-analysis suggests.

SGLT2-inhibitors: No Benefit in Hospitalized COVID-19 - Vimarsana News

SGLT2-inhibitors: No Benefit in Hospitalized COVID-19

However, an important take-home message from this new meta-analysis is that these widely used medications appeared to be safe even in acutely ill hospitalized patients, the researchers say.